Vystar Corp Stock Price, News & Analysis

Vystar Corporation (OTCQB: VYST) has introduced a breakthrough ultrasoft 55 density Vytex natural latex mattress topper to its product lineup. The company has developed proprietary molding technology that enables the production of large-format ultrasoft latex sheets while maintaining consistent density, previously only achievable in smaller items like pillows.

The new topper features a 55 density rating (14 ILD equivalent) and is available in various sizes up to California king with 1-3 inch thickness options. Key features include enhanced durability, pressure point relief, natural anti-microbial properties, and virtually allergen-free composition with 99.8% of proteins removed. The product is environmentally friendly, being sustainably produced and biodegradable.

Vystar (OTCQB: VYST) has secured a significant legal victory as the Second Circuit Court affirmed the dismissal of a $4.2 million claim by EMA Financial LLC related to a toxic convertible note issue. The original November 2024 district court ruling not only dismissed EMA's complaint but also awarded Vystar legal fees.

While the Second Circuit's July 17, 2025 decision upholds the dismissal, it did not reverse the district court's denial of Vystar's counterclaims. The case now returns to district court for determination of legal fees, with Vystar having accrued approximately $1 million from 2018 to date. This marks a historic victory as the first successful defense by a micro-cap issuer against EMA Financial's breach of contract claims on convertible notes.

Vystar Corporation (OTCQB: VYST) has launched a redesigned website www.vytex.com alongside a brand refresh to enhance customer engagement and digital presence. The company's flagship product, Vytex, is positioned as a superior alternative to traditional memory foam and polyurethane materials for mattress toppers and pillows.

The material boasts several key features including 99.8% protein and impurity removal, extended durability with decades of resilience, and environmentally-friendly characteristics such as biodegradability and reduced chemical usage in manufacturing. CEO Jamie Rotman emphasizes Vytex's advantages in comfort, durability, and eco-friendliness, particularly noting its superiority over conventional memory foams that can off-gas and retain moisture.

Vystar Corporation (VYST) has developed a revolutionary next-generation RXAIR prototype utilizing the patented Hughes Reactor technology for advanced air purification. The technology, developed by Dr. Bryan Stone, combines ultrasonics and ultraviolet energy in a unique approach that offers superior control of airborne diseases. The system features a "kill chamber" that provides uniform UV exposure and can extend its purification capabilities beyond the unit to eliminate organisms on nearby surfaces - a significant advancement over traditional air purifiers.

The Hughes Reactor converts liquid or gas flow into powerful sound waves without moving parts, enabling various applications in air and water purification. The technology can enhance chemical reactions, improve flow measurement, and provide instant mixing capabilities.

Vystar Corporation (OTCQB: VYST) announced its upgrade from Pink Sheets to the OTCQB Exchange following Form 15C-211 approval. The company reports 17,400,614 shares outstanding and has successfully eliminated $11 million in debt through removing $5 million in Rotmans lease debt and $6 million in loans.

The company is focusing on three main business areas:

• Vytex - Allergy-free natural rubber latex products including foam, gloves, and condoms
• RXAIR - Air purification systems ranging from $500 personal units to $6,000 industrial units, with over 20,000 residential and 400 hospital units sold
• Fluid Energy Conversion (FEC) - Hughes Reactor technology for various applications including flow meters, water treatment, and combustion enhancement

Vystar's strategy involves growing existing product lines and exploring M&A opportunities, leveraging its $60 million loss carry forward and patent-protected product portfolio.

Vystar Corporation (OTCQB: VYST) announced that Rotmans, New England's largest furniture and flooring retailer, will begin liquidation on October 14, 2022, following a history of over 60 years in business. The liquidation sale offers over $20 million in deeply discounted inventory, including furniture and mattresses. Steve Rotman, the retiring CEO, has been a significant figure in the furniture industry and will shift focus to his role at Vystar. Despite the closure, Vystar continues to promote its environmentally friendly products, including Vytex Natural Rubber Latex and RxAir UV light air purification technologies.

Vystar Corporation (OTCQB: VYST) announced plans to split into two companies via a dividend, retaining Rotmans Furniture and adding Vytex latex to the RxAir NewCo spin-off. This strategic move aims to attract potential reverse mergers, which could yield higher revenue ($100-$150 million) and profits ($10-$15 million). The dividend record date is set for June 30, 2022. Vystar's focus on the retail furnishings and mattress market is designed to enhance appeal to merger partners. The successful combination of Vystar and Rotmans could create a cleaner, more valuable entity.

Vystar Corporation (OTCQB: VYST) announced the integration of its subsidiary Fluid Energy Conversion, Inc. (FEC) into the RxAir spin-off, set for early 2022. This strategic move aims to enhance research and development in air and water purification, leveraging FEC's patented Hughes Reactor technology. The spin-off will allow Vystar to concentrate on its retail business and environmentally friendly products. Dr. Bryan Stone will lead RxAir NewCo, focusing on advancing air purification methods and addressing critical clean water needs due to severe droughts.

Vystar Corporation (OTCQB: VYST) plans to spin off its RxAir UV light air purification business into a separate publicly traded entity, RxAir NewCo. This move is designed to create a pure-play investment opportunity for shareholders, who will receive shares in RxAir NewCo as a dividend. The Record Date for this dividend is January 5, 2022, and shareholders will receive approximately 2857 shares of RxAir NewCo for every 100,000 shares of Vystar held. The expected opening share price for RxAir NewCo is projected to be $2.00.